Emergent Biosolutions
EBS
EBS
198 hedge funds and large institutions have $524M invested in Emergent Biosolutions in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 87 increasing their positions, 49 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 39
39% less capital invested
Capital invested by funds: $854M → $524M (-$330M)
Holders
198
Holding in Top 10
–
Calls
$877K
Puts
$595K
Top Buyers
| 1 | +$17.7M | |
| 2 | +$13.5M | |
| 3 | +$7.55M | |
| 4 |
BlackRock
New York
|
+$6.63M |
| 5 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$5.73M |
Top Sellers
| 1 | -$14.4M | |
| 2 | -$12.7M | |
| 3 | -$10.5M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$6.44M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$4.63M |